Sylvia Reyes
Psychiatry · New York, NYNPI 1144208539
Payments from drug & device makers
Across 413 payments — averaging $36.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$4K
- Sunovion Pharmaceuticals Inc.$3K
- Alkermes, Inc.$2K
- Neurocrine Biosciences, Inc.$2K
- Johnson & Johnson$2K
- Teva Pharmaceuticals USA, Inc.$873
- plus $3K from 12 others
What the payments were for
- Food & beverage$14,964100%
- Education$430%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 120 | $3,508 |
| Sunovion Pharmaceuticals Inc. | 102 | $3,189 |
| Alkermes, Inc. | 31 | $1,643 |
| Neurocrine Biosciences, Inc. | 17 | $1,572 |
| Johnson & Johnson | 21 | $1,508 |
| Teva Pharmaceuticals USA, Inc. | 9 | $873 |
| AbbVie(2 entities) | 37 | $727 |
| Ironshore Pharmaceuticals Inc. | 1 | $435 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $404 |
| Lundbeck LLC | 26 | $338 |
| Indivior Inc. | 5 | $217 |
| Vanda Pharmaceuticals Inc. | 12 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $128 |
| Shire North American Group Inc | 10 | $127 |
| Avanir Pharmaceuticals, Inc. | 1 | $123 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Corium, LLC | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$3,915
- INGREZZA$1,455
- REXULTI$1,115
- ARISTADA INITIO$979
- LATUDA$741
- AUSTEDO$741
- INVEGA SUSTENNA$725
- LYBALVI$500
- SPRAVATO$468
- Jornay PM 20mg capsules (Bottle of 100)$435
- ABILIFY MAINTENA$359
- VRAYLAR$248
- CAPLYTA$127
- PERSERIS$125
- AJOVY$125
- NUEDEXTA$123
- VIVITROL$118
- INVEGA TRINZA$107
- INVEGA$107
How this compares
$15,008 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in New York
- Michael LiebowitzNew York$7.1M
- Paul EderNew York$2.7M
- Lenard AdlerNew York$1.8M
- Ram ShrivastavaNew York$1.8M
- Jonathan KaneNew York$1.8M
- Eric HollanderNew York$1.4M
- William HapworthNew York$1.3M
- Manish ZinzuvadiaNew York$1.3M
- Jianping ChenNew York$1.2M
- Anthony ZoghbiNew York$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.